Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (1) , 5-11
- https://doi.org/10.1016/s0959-8049(05)80008-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- pS2 expression in primary breast carcinomas: Relationship to clinical and histological features and survivalBreast Cancer Research and Treatment, 1992
- Prognostic value of total cathepsin D in breast tumorsBreast Cancer Research and Treatment, 1991
- Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancersEuropean Journal of Cancer and Clinical Oncology, 1991
- A prognostic score in histological node negative breast cancerBritish Journal of Cancer, 1990
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.Journal of Clinical Oncology, 1989
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cellsBiochimie, 1988
- Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.Journal of Clinical Oncology, 1988